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ABSTRACT
Although patients with a history of hymenoptera
venom anaphylaxis showed significantly reduced
plasma levels of angiotensin-I and angiotensin-II
compared to controls, there is no study in the litera-
ture to investigate the renin angiotensin aldosterone
system (RAAS) in patients with anaphylactic reaction
induced by immunotherapy. The purpose of this study
is to determine the role of the renin angiotensin
aldosterone system in patients who had an anaphy-
lactic reaction induced by allergen immunotherapy
with pollen, house-dust and mold extracts. Plasma
levels of angiotensin-I, angiotensin-II, angiotensin
converting enzyme and aldosterone were measured
in 20 patients who experienced anaphylaxis during
allergen immunotherapy. The control group consis-
ted of 15 immunotherapy patients without any history
of anaphylaxis. The Mann–Whitney U-test was per-
formed for comparison of the two groups, and a
P value less than 0.05 was considered statistically
significant. Angiotensin-I, angiotensin-II, angiotensin
converting enzyme and aldosterone levels were
similar in both the study and control groups and no
statistical significance was found between the two
groups (P > 0.05). The RAAS does not appear to play
a role in the pathogenesis of anaphylactic reactions
due to allergen immunotherapy with pollen, house-
dust and mold extracts.
Key words: anaphylaxis, immunotherapy, renin angio-
tensin system.
INTRODUCTION
Acute anaphylaxis is a potentially life-threatening clinical
picture. Mast cells and basophils, which are activated by
immunoglobulin E (IgE) and allergen, play a prominent
role in these reactions. However, recent studies have shown
that non-immunologic factors, such as renin angiotensin
aldosterone system (RAAS), may play a role in the patho-
physiology of the anaphylactic reactions. The role of the
RAAS in cardiovascular function and disease has long
been recognized. The RAAS acts systemically and locally to
influence vascular tone, blood volume and myocardial
contractility. It is also an important back-up mechanism
for maintaining arterial blood pressure during circulatory
challenges.1 Patients with a history of anaphylactic reac-
tions induced by bee or wasp venom showed significantly
reduced serum angiotensin-I (A-I) and angiotensin-II (A-II)
levels compared to controls.2–4
In this study, we investigated the role of the RAAS in the
anaphylactic reactions triggered by allergen immuno-
therapy with pollen, house-dust and mold extracts.
PATIENTS AND METHODS
The study was carried out at the Department of Allergy at
the Gülhane Military Medical Academy in Ankara, Turkey
and consisted of 20 patients (13 males, 7 females) with
allergic rhinitis and bronchial asthma. All patients had
experienced severe anaphylaxis during the build-up period
of allergen immunotherapy with aqueous extracts of aero-
allergens. The control group consisted of 15 sex, age and
diagnosis matched immunotherapy patients (10 males,
5 females)  without a history of anaphylaxis.
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Serum levels of A-I, A-II, angiotensin converting enzyme
(ACE) and aldosterone were measured in both groups.
Venous blood was withdrawn soon after the anaphylaxis
from a cubital vein directly into a plain glass tube. The
serum samples were frozen at –70°C until the tests were
performed.
The radio-immunoassay method was used to meas-
ure A-I (SORIN Biomedica, Saluggia-Vercelli, Italy), A-II
(EURO Diagnostic B.V., Arnhem, Holland) and aldosterone
(Diagnostic System Laboratories Inc., Texas, USA) levels.
Statistical analysis was performed using the Mann–
Whitney U-test with SPSS/PC (Statistical Program for the
Social Sciences, Version 6.00). A  P value less than 0.05
was considered statistically significant.
RESULTS
Mean age was 27.45 ± 2.06 years in the study group
and 29.27 ± 2.23 years in control group. Results of the
study and control group are presented in Table 1.
The A-I, A-II, ACE and aldosterone levels were similar
in both groups and the difference between the two groups
was not statistically significant (P > 0.05). (Table 2.)
DISCUSSION
Circulation has several protective mechanisms which
maintain perfusion of vital organs in the event of an
acute hypotensive episode. Regulation of these circu-
latory responses is provided by the integrated effects of
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Table 1. Results of the study and control groups
Reference values: Angiotensin I, < 5.7 (ng/mL); ACE, 5–10 (U/L); Angiotensin II, 5–15 (pg/mL); Aldosterone, 30–200 (pg/mL).
A-I, Angiotensin-1; A-II, Angiotensin-II; ACE, angiotensin converting enzyme
Table 2. Comparison of the mean values of parameters (± SEM) in study and control groups
ACE, angiotensin converting enzyme.
Study group Control group
Patient A-I A-II ACE Aldosterone Patient A-I A-II ACE Aldosterone
(ng/mL) (pg/mL) (U/L) (pg/mL) (ng/mL) (pg/ml) (U/L) (pg/mL)
1 0.2 7.3 5 116.0 1 0.2 7.4 6 218.2
2 0.1 20 8 115.3 2 0.5 8.5 7 198.3
3 4 4 6 224.8 3 1.4 15.8 6 200.5
4 3.8 8.5 5 340 4 3.4 6.2 6 184.2
5 0.8 7.5 7 348.5 5 3.8 7.8 5 239.2
6 0.1 10 5 301.4 6 0.2 19 6 298.8
7 0.7 20 9 226 7 0.6 8.6 6 274.3
8 0.4 22 5 147.3 8 0.5 9.6 9 280.4
9 1.2 26 5 125 9 1.1 9.6 6 186
10 4.4 2 7 289.8 10 2.3 3 6 198.3
11 3.6 20 9 288 11 2.4 5 5 156
12 0.3 5 5 303.1 12 1.0 7.2 5 153.2
13 0.3 9.6 6 223.9 13 0.6 16.4 6 280.4
14 0.1 7.6 5 175 14 0.5 18.6 5 210
15 1.5 8.2 7 172.8 15 1.6 6.4 6 120.6
16 0.7 6.4 6 225
17 0.6 5.2 5 264
18 0.2 7.6 5 221.8
19 1.8 8.1 7 172.1
20 1.5 6.4 5 224.1
Study group Control group P
n = 20 n = 15
Angiotensin-I (ng/mL) 1.31 ± 0.32 1.36 ± 0.29 > 0.05
Angiotensin-II (pg/mL) 10.57 ± 1.54 99.4 ± 1.30 > 0.05
ACE (U/L) 6.6 ± 0.70 6.00 ± 0.26 > 0.05
Aldosterone (pg/mL) 225.2 ± 16.07 209.23 ± 13.53 > 0.05
both neural and hormonal systems. The sympathetic
nervous system and the RAAS are the most extensively
studied systems. The RAAS was first recognized as a clas-
sical endocrine system with effects mediated entirely by
circulating hormones. However, it has been recently
demonstrated that all components of the system are
present in many tissues.5,6
Hermann and co-workers reported that the plasma
concentrations of all components of the RAAS are re-
duced in patients with a history of anaphylactic reactions
to hymenoptera venom. Likewise, A-II concentrations in
their leukocytes were significantly reduced and a signifi-
cant correlation between the severity of clinical symptoms
and the A-II levels was found. These findings suggested
that the renin-angiotensin system may play an important
role as a counteracting factor in hymenoptera venom
anaphylaxis.4,7–9
It is well known that the major risk of allergen immuno-
therapy is the development of a systemic anaphylactic
reaction. Factors determining the risk of an allergic res-
ponse are not fully understood. Although immunologic
factors are important, non-immunologic factors such as a
defect in the circulating RAAS, may also play a role in the
pathogenesis of anaphylaxis. The impaired activity of the
RAAS may contribute to the dramatic fall in blood pres-
sure in anaphylactic shock. Whether this is confined to
anaphylaxis resulting from hymenoptera stings, or is a
feature of other forms of anaphylaxis, remains unclear.6
Advanced studies have shown that in patients with
successful immunotherapy who tolerated the sting of a
living insect, renin, A-I and A-II were significantly higher than
in patients without immunotherapy. After immunotherapy,
the levels of renin, A-I and A-II were similar to those found in
healthy nonallergic controls.10 The reversal of the defect
after hyposensitization indicates an acquired phenomenon,
perhaps with an immunologic origin. Cross-reactivity of
antibodies to hymenoptera venom and angiotensinogen
may be one possible explanation.6 In addition, it has been
found in animal studies that the passive transfer of anti-
bodies to angiotensinogen also decreases plasma renin
activity despite a reduction in blood pressure.11
Our study group consisted of patients with allergic
rhinitis and bronchial asthma who were sensitive to house
dusts, pollens and molds. Anaphylactic reactions occurred
in the early phase (build-up period) of immunotherapy.
The A-I, A-II, ACE and aldosterone levels were found
within normal ranges soon after anaphylaxis. There was
no statistically significant difference between the study
group and the controls (P > 0.05). Although Hermann
and Ring reported reduced plasma levels of RAAS com-
ponents in their patients with anaphylactic reactions to
hymenoptera venom, we did not find any difference in
angiotensin II levels between patients with immunotherapy-
induced anaphylactic reactions and the control group.2,3
In another study, decreased levels of angiotensin II in
white blood cells of patients with anaphylactic reactions
to hymenoptera venom was reported. In addition, it has
also been demonstrated that decreased levels of angio-
tensin II have a close relationship with the severity of the
symptoms.
A number of studies have reported that all patients
have anaphylactic reactions to hymenoptera venom;
however, other factors leading to anaphylactic reactions
have not been considered in these studies. There may be
a close relationship between anaphylactic reactions to
hymenoptera venom and angiotensin II, as pointed out
in these studies. In fact, a cross-reactivity between anti-
body to hymenoptera venom and angiotensin has been
suggested. After making a decision for the relation-
ship between the RAAS and anaphylactic reactions to
hymenoptera venom, the relationship among other ana-
phylactic reactions and the RAAS become more impor-
tant in explaining the pathophysiology of these types of
reactions. Although an elevation of angiotensin II levels
in patients with acute severe asthma has been shown
in some studies, we did not find any difference between
asthmatic patients who had shown immunotherapy-
induced anaphylactic reactions and the control group.
The RAAS is activated in acute severe asthma, although
not in all asthmatics. The mechanism of this activation is
unclear, but recent evidence has shown elevation of renin
and angiotensin II in response to nebulized and intra-
venous salbutamol.12,13
It can be seen that this phenomenon may be confined
to only hymenoptera venom sensitive patients. However,
further studies should be planned to fully define the
responsiveness of the RAAS in sensitized subjects.
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